Drug
Vert 002
Vert 002: highest development phase Phase 1/2, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| VERT-002 NCT06669117 | Phase 1/2 | Solid Tumor |
Latest
No recent events.
Follow Vert 002 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.